"Headed by Dr. Stephanie Mehlis and Dr. Joel Joyce, we are home to various pharmaceutical clinical studies that investigate the safety and effectiveness of novel and currently-available drugs for many dermatological conditions. We work to make participation in our studies as easy and comfortable as possible, making sure that every candidate for dermatology clinical research understands the process and knows what to expect."

During the past decade, NorthShore University HealthSystem Dermatology Clinical Trials Unit conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NorthShore University HealthSystem Dermatology Clinical Trials Unit" #1 collaborator was "Immune Tolerance Network (ITN)" with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NorthShore University HealthSystem Dermatology Clinical Trials Unit" are "Alopecia Areata" (3 trials), "Dermatitis, Atopic" (3 trials), "Allergic Reaction" (1 trials), "Atopic Dermatitis" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "NorthShore University HealthSystem Dermatology Clinical Trials Unit" in a lesser frequency.

Most popular intervention types in "NorthShore University HealthSystem Dermatology Clinical Trials Unit" are "Drug" (7 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "PF-06651600" (3 trials), "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials) and "Abrocitinib 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "NorthShore University HealthSystem Dermatology Clinical Trials Unit" are 8 trials for "All" genders.

Currently, there are NaN active trials in "NorthShore University HealthSystem Dermatology Clinical Trials Unit". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in NorthShore University HealthSystem Dermatology Clinical Trials Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NorthShore University HealthSystem Dermatology Clinical Trials Unit, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".